Literature DB >> 22681411

The development of a patient partnership programme and its impact on quality improvements in a comprehensive haemophilia care service.

A Grogan1, M Coughlan, B O' Mahony, G McKee.   

Abstract

It has long been advocated that patient input in service quality development is essential. We have developed a model of quality evaluation and improvement within a comprehensive haemophilia service, and describe the issues and improvements that resulted from the process. The project utilized an action research methodology. Seven patients were recruited from the haemophilia service for the initial focus groups. The main themes initially explored were as follows: patient experience of the outpatient, inpatient and weekend services and provision of information. The focus group data were analysed using basic content analysis. The main themes the initial focus group identified were the need to optimize the annual review, emergency care and inpatient facilities. Following this, the haemophilia care team worked on improving these issues. At the second focus group the patients contributed at a higher level - patient participation. Patients assisted in addressing outstanding issues such as ID alert card content and the algorithm of care for emergency services. Finally, a patient panel was developed and the relationship became one of direct negotiation and partnership with the haemophilia team to address issues within the service. The expectations and needs of patients attending the haemophilia comprehensive care service are complex. The process of including patients as partners at the highest level of patient involvement evolved and proved an effective method of service evaluation and development, facilitating lateral decision-making, not only improving care directly, but also improving the user experience.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22681411     DOI: 10.1111/j.1365-2516.2012.02885.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  7 in total

Review 1.  Effects of consumers and health providers working in partnership on health services planning, delivery and evaluation.

Authors:  Dianne Lowe; Rebecca Ryan; Lina Schonfeld; Bronwen Merner; Louisa Walsh; Lisa Graham-Wisener; Sophie Hill
Journal:  Cochrane Database Syst Rev       Date:  2021-09-15

2.  Persons with Haemophilia in Sweden- Experiences and Strategies in Everyday Life. A Single Centre Study.

Authors:  Elisabeth Brodin; Katharina S Sunnerhagen; Fariba Baghaei; Marie Törnbom
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

Review 3.  Motives for meaningful involvement in rural AIDS service organizations.

Authors:  Barbara L Paterson; Steven Ross; Ted Gaudet
Journal:  AIDS Care       Date:  2013-10-10

4.  Describing the implementation of an innovative intervention and evaluating its effectiveness in increasing research capacity of advanced clinical nurses: using the consolidated framework for implementation research.

Authors:  Gabrielle McKee; Margaret Codd; Orla Dempsey; Paul Gallagher; Catherine Comiskey
Journal:  BMC Nurs       Date:  2017-05-02

5.  The patient's view on rare disease trial design - a qualitative study.

Authors:  C M W Gaasterland; M C Jansen- van der Weide; M J du Prie-Olthof; M Donk; M M Kaatee; R Kaczmarek; C Lavery; K Leeson-Beevers; N O'Neill; O Timmis; V van Nederveen; E Vroom; J H van der Lee
Journal:  Orphanet J Rare Dis       Date:  2019-02-07       Impact factor: 4.123

6.  Impact, obstacles and boundaries of patient partnership: A qualitative interventional study in Lebanon.

Authors:  Alaa Yehya Dayekh; Mohammad Naseridine; Fatima Dakroub; Adel Olleik
Journal:  PLoS One       Date:  2022-07-07       Impact factor: 3.752

Review 7.  Measuring therapeutic relationship in the care of patients with haemophilia: A scoping review.

Authors:  Erin McCabe; Maxi Miciak; Liz Dennett; Patricia Manns; Christine Guptill; Jeremy Hall; Douglas P Gross
Journal:  Health Expect       Date:  2018-08-29       Impact factor: 3.377

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.